Gargoyle Investment Advisor’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-48,354
Closed -$2.8M 115
2018
Q2
$2.8M Sell
48,354
-419
-0.9% -$23.6K 1.56% 7
2018
Q1
$2.54M Hold
48,773
1.04% 30
2017
Q4
$2.62M Buy
48,773
+6,708
+16% +$372K 1.04% 37
2017
Q3
$2.57M Hold
42,065
0.94% 40
2017
Q2
$2.57M Hold
42,065
1.02% 38
2017
Q1
$2.55M Hold
42,065
0.98% 35
2016
Q4
$2.36M Sell
42,065
-7,745
-16% -$453K 0.92% 49
2016
Q3
$2.97M Sell
49,810
-9,328
-16% -$545K 1.12% 14
2016
Q2
$3.25M Hold
59,138
1.21% 8
2016
Q1
$2.99M Buy
59,138
+4,857
+9% +$238K 1.01% 11
2015
Q4
$2.73M Buy
54,281
+305
+0.6% +$15.4K 1.11% 30
2015
Q3
$2.54M Hold
53,976
1.04% 31
2015
Q2
$2.93M Buy
53,976
+16,768
+45% +$940K 1.12% 27
2015
Q1
$2.04M Buy
+37,208
New +$2.11M 0.77% 66

Other funds holding MRK

Gargoyle Investment Advisor's MRK Position: Q3 2018 in Review

Gargoyle Investment Advisor sold out of Merck (MRK) in Q3 2018, closing a stake of 48,354 shares — an estimated $2.8M sold.

Gargoyle Investment Advisor first reported a position in MRK in Q1 2015 and held it in 14 quarters. The position peaked at $3.25M in Q2 2016. 2,056 funds tracked by Wall St. Rank hold MRK as of Q3 2018.

  • Gargoyle Investment Advisor reported no remaining Merck position as of Q3 2018 after selling out during the quarter.
  • Gargoyle Investment Advisor sold 48,354 Merck shares in Q3 2018, an estimated $2.8M.
  • Gargoyle Investment Advisor first reported a position in Merck in Q1 2015 and held it in 14 quarters.
  • Gargoyle Investment Advisor's Merck position peaked at $3.25M in Q2 2016.
  • 2,056 funds tracked by Wall St. Rank held Merck as of Q3 2018.

Based on Gargoyle Investment Advisor's 13F filing for Q3 2018, filed 14 Nov 2018.